{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fqa-on-hiv-prep-episode-6-on-cisgender-women-6pkmKM6v","width":444,"version":"1.0","type":"rich","title":"Q&A on HIV PrEP: Episode 6 on Cisgender Women","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/17b4a3bf-7ca8-4f96-a81c-4803e4c30e75/prep-barriers-vm-prp5566-pod710-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/0497bb6e-13cb-4c09-8ebc-2ff144be99b7\" height=\"200\" width=\"100%\" title=\"Q&amp;A on HIV PrEP: Episode 6 on Cisgender Women\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Hear Meredith Clement, MD, and Whitney Irie, MSW, PhD, address key considerations for PrEP uptake among cisgender women, including strategies to leverage clinic staff and overcoming key barriers limiting PrEP uptake in cisgender women (eg, stigma, risk perception)."}